Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Abcam PLC (ADR) - SIC # 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ABCM
Nasdaq
2835
http://www.abcam.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Abcam PLC (ADR)
Abcam plc's (LON:ABC) Intrinsic Value Is Potentially 43% Above Its Share Price
- Jun 18th, 2022 8:24 am
Are Abcam plc's (LON:ABC) Mixed Financials Driving The Negative Sentiment?
- May 2nd, 2022 9:35 am
Abcam the most awarded company at 2022 industry awards
- Mar 25th, 2022 12:40 pm
Wall Street Analysts Predict a 27% Upside in Abcam PLC Sponsored ADR (ABCM): Here's What You Should Know
- Mar 18th, 2022 2:00 pm
Abcam PlcĀ Results for the 12- and 18-month periods ended 31 December 2021
- Mar 14th, 2022 12:00 pm
Investing in Abcam (LON:ABC) five years ago would have delivered you a 38% gain
- Mar 10th, 2022 9:46 am
Abcam Collaborates With Twist Bioscience to Enhance Antibody Discovery for Diagnostic and Research Applications
- Feb 1st, 2022 9:00 am
Is Abcam plc (LON:ABC) Trading At A 20% Discount?
- Jan 9th, 2022 6:02 am
Alamar Biosciences partners with Abcam to drive understanding of the human proteome
- Jan 4th, 2022 9:00 am
Can Mixed Fundamentals Have A Negative Impact on Abcam plc (LON:ABC) Current Share Price Momentum?
- Nov 10th, 2021 4:16 am
Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome
- Nov 2nd, 2021 12:00 pm
Abcam completes $340m strategic acquisition and expands kit capacity and capability
- Oct 27th, 2021 6:00 am
29% Constant Currency Revenue Growth in H2 as Lab Activity Gradually Recovers and Demand for Abcam In-house Products Increases
- Sep 13th, 2021 11:00 am
Abcam To Acquire Supplier BioVision For $340M In Cash
- Aug 2nd, 2021 11:38 am
Abcam to Acquire BioVision for $340 million
- Aug 2nd, 2021 6:00 am
New Strong Sell Stocks for July 29th
- Jul 29th, 2021 1:06 pm
Is Abcam plc (ABCM) A Smart Long-Term Buy?
- Jul 13th, 2021 4:44 pm
Abcam opens new US facility in Boston, MA
- Jul 13th, 2021 11:00 am
Scroll